Author:
Haberkamp Marion,Moseley Jane,Athanasiou Dimitrios,de Andres-Trelles Fernando,Elferink André,Rosa Mário Miguel,Magrelli Armando
Subject
Genetics(clinical),Clinical Neurology,Neurology,Pediatrics, Perinatology, and Child Health
Reference7 articles.
1. Evidence-based care in Duchenne muscular dystrophy;McDonald;Lancet Neurol,2018
2. Revised Guideline on the clinical investigation of medicinal products for the treatment of Duchenne and Becker muscular dystrophy. EMA/CHMP/236981/2011, Corr. 1,2016
3. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy;McDonald;Muscle Nerve,2010
4. Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study;Voit;Lancet Neurol,2014
5. Qualification Opinion, Stride velocity 95th centile as a secondary endpoint in Duchenne Muscular Dystrophy measured by a valid and suitable wearable device,2019
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献